Relative quantification of progressive changes in healthy and dysferlin-deficient mouse skeletal muscle proteomes

Adriana E Golding; Wenping Li; Paul S Blank; Stephanie M Cologna; Joshua Zimmerberg

doi:10.1002/mus.27975

Relative quantification of progressive changes in healthy and dysferlin-deficient mouse skeletal muscle proteomes

Muscle Nerve. 2023 Nov;68(5):805-816. doi: 10.1002/mus.27975. Epub 2023 Sep 14.

Authors

Adriana E Golding^{1

2}, Wenping Li³, Paul S Blank¹, Stephanie M Cologna³, Joshua Zimmerberg¹

Affiliations

¹ Section on Integrative Biophysics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
² Section on Intracellular Protein Trafficking, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
³ Department of Chemistry, University of Illinois Chicago, Chicago, Illinois, USA.

PMID: 37706611
DOI: 10.1002/mus.27975

Abstract

Introduction/aims: Individuals with dysferlinopathies, a group of genetic muscle diseases, experience delay in the onset of muscle weakness. The cause of this delay and subsequent muscle wasting are unknown, and there are currently no clinical interventions to limit or prevent muscle weakness. To better understand molecular drivers of dysferlinopathies, age-dependent changes in the proteomic profile of skeletal muscle (SM) in wild-type (WT) and dysferlin-deficient mice were identified.

Methods: Quadriceps were isolated from 6-, 18-, 42-, and 77-wk-old C57BL/6 (WT, Dysf^+/+ ) and BLAJ (Dysf^-/- ) mice (n = 3, 2 male/1 female or 1 male/2 female, 24 total). Whole-muscle proteomes were characterized using liquid chromatography-mass spectrometry with relative quantification using TMT10plex isobaric labeling. Principle component analysis was utilized to detect age-dependent proteomic differences over the lifespan of, and between, WT and dysferlin-deficient SM. The biological relevance of proteins with significant variation was established using Ingenuity Pathway Analysis.

Results: Over 3200 proteins were identified between 6-, 18-, 42-, and 77-wk-old mice. In total, 46 proteins varied in aging WT SM (p < .01), while 365 varied in dysferlin-deficient SM. However, 569 proteins varied between aged-matched WT and dysferlin-deficient SM. Proteins with significant variation in expression across all comparisons followed distinct temporal trends.

Discussion: Proteins involved in sarcolemma repair and regeneration underwent significant changes in SM over the lifespan of WT mice, while those associated with immune infiltration and inflammation were overly represented over the lifespan of dysferlin-deficient mice. The proteins identified herein are likely to contribute to our overall understanding of SM aging and dysferlinopathy disease progression.

Keywords: dysferlin; dysferlinopathy; muscle wasting; proteome; skeletal muscle.

Abstract

Grants and funding